Tineke Meijers

Tineke Meijers is a seasoned professional in business development, particularly within drug discovery and translational sciences. Currently serving as Senior Director of Business Development at Inotiv since February 2024, Tineke Meijers also operates Tineke Meijers Consulting Inc. as an Executive Business Development Consultant since 2005. Previous roles include Business Development Consultant at The TIM Company and TRISKELION, as well as VP of Business Development for Predictive Health Technologies at TNO. Tineke Meijers held the position of Executive Director at the Canadian Arthritis Network and worked as a Drug Development Specialist at Apotex Inc. and a Research Associate at Eli Lilly. Academically, Tineke Meijers earned an MSc in Medical Biology from the University of Amsterdam, a PhD in Clinical Biochemistry from The University of Sheffield, and completed a postdoctoral fellowship in Arthritis and Orthopaedics at Hôpitaux Shriners pour enfants - Canada.